Current Edition

FDA Continues to strengthen Paediatrics
Volume 12 Issue 2

FDA Continues to Strengthen Paediatric Study Expectations

After a three-year reprieve, a new US paediatric study requirement kicks in on August 18, 2020. The US Food and Drug Administration Reauthorization Act of …

Continue Reading →
Lessons Learned from the Clinical
Volume 12 Issue 2

Lessons Learned from the Clinical Trial Trenches: How to Use Patient Engagement Technology Successfully

Taken within the context of clinical trials, patient engagement (PE) technology must be treated with the same reverence as giftgiving. Put simply, organisations who don’t …

Continue Reading →
Technology at the Edge_Emerging
Volume 12 Issue 2

Technology at the Edge: Emerging Use of Actigraphy as an Outcome Measure

Wearable devices incorporating actigraphic technologies are transforming the way researchers aggregate, display and interpret health-related data. These devices, and the mobile software applications built to …

Continue Reading →
Home Trial Support
Volume 12 Issue 2

Home Trial Support

Patient-centricity has been at the core of MRN since its inception in 2006, so its impact is substantial. However, the term “patientcentricity” can have different …

Continue Reading →